North Carolina vs Texas on USAspending: $6.3B vs $72.7B

A shared pharma peak on unmatched stocks

Texas’s $72.7B stacked stock sits well above North Carolina’s $6.3B. Census population leans Texas: 31,290,831 versus 11,046,024. Intensity follows the dollar ranking hard. $66.77 per capita in North Carolina is far cooler than Texas’s $686.1. Cite those packet ratios beside the Census counts; they are not a second copy of $72.7B and $6.3B.

Award volume is the ranking that stays relatively tight. North Carolina’s 429,746 awards versus Texas’s 530,634 is a closer row count than the dollar gap. Row count is not average award size. Cite USAspending.gov. Do not invent a mean from 429,746 or 530,634.

Pharmaceutical preparation manufacturing on both sides

North Carolina’s lead NAICS is pharmaceutical preparation manufacturing. Texas’s lead NAICS is the same label. A shared drug-manufacturing peak is a first filter on $6.3B and $72.7B, not a claim that the two mixes are interchangeable. The same industry name does not make $66.77 and $686.1 the same intensity.

The 429,746 North Carolina awards and 530,634 Texas awards include many actions outside that pharmaceutical label. Use the North Carolina and Texas state hubs for agencies and recipients. Both peaks are USAspending.gov obligation mixes. Outlays are not in the packet.

North Carolina’s 429,746 awards and $737.5M FY2026 slice sit on 11,046,024 residents. Texas’s 530,634 awards and $21.5B sit on 31,290,831. The shared pharmaceutical preparation manufacturing label does not make $6.3B and $72.7B interchangeable. $66.77 versus $686.1 remains the intensity ranking. Cite USAspending.gov.

FY2026: North Carolina’s $737.5M versus Texas’s $21.5B

Fiscal year 2026 obligations are $737.5M in North Carolina and $21.5B in Texas. Recency preserves Texas’s stacked dollar lead. Treat the year as a recency slice of obligations, not as Treasury cash already paid.

Do not divide $737.5M or $21.5B by 429,746 or 530,634 all-years awards. Spending per capita of $66.77 and $686.1 already sits beside Census counts of 11,046,024 and 31,290,831. Cite USAspending.gov for both cuts.

What $66.77 looks like on 11,046,024 residents

North Carolina’s $6.3B on 11,046,024 people produces $66.77 per capita, much cooler than Texas’s $686.1 on 31,290,831. The shared pharmaceutical peak sits on that cooler ratio and on 429,746 awards. The $737.5M FY2026 slice is the recency cut on the smaller stock.

Texas’s $72.7B stacked stock, 530,634 awards, and $21.5B latest-year amount remain the larger dollar file. Read two pharmaceutical peaks as a same-label, unmatched-scale pair. Keep every dollar figure labeled as a USAspending.gov obligation.

How to read North Carolina versus Texas

Read Texas first on stacked dollars ($72.7B vs $6.3B), population (31,290,831 vs 11,046,024), spending per capita ($686.1 vs $66.77), and FY2026 ($21.5B vs $737.5M). Award volume is closer: 530,634 versus 429,746. Note that both lead industries are pharmaceutical preparation manufacturing.

The comparison hub holds the tables. The North Carolina and Texas hubs hold agencies and recipients. Outlays are a different series. Cite USAspending.gov. Keep $66.77 and $686.1 labeled as Census-based obligation ratios.

Same pharmaceutical label, a $66.77 ratio

Pharmaceutical preparation manufacturing is the lead NAICS on both $6.3B in North Carolina and $72.7B in Texas. Award counts are relatively close, 429,746 versus 530,634. Intensity is not. $66.77 on 11,046,024 residents versus $686.1 on 31,290,831 is a wide gap. FY2026 of $737.5M versus $21.5B preserves Texas’s stacked lead. A shared drug-manufacturing peak is a first filter, not a matched mix.

Cite USAspending.gov. Keep $66.77 and $686.1 labeled as Census-based obligation ratios. Outlays are not in the packet. Use the comparison hub for tables. Use the North Carolina and Texas hubs for agencies and recipients. Do not invent a mean from 429,746 or 530,634.

Questions

Does North Carolina or Texas have more federal spending?

Texas leads stacked USAspending.gov obligations $72.7B to North Carolina’s $6.3B, spending per capita $686.1 to $66.77, awards 530,634 to 429,746, and FY2026 obligations $21.5B to $737.5M. Population is 11,046,024 in North Carolina and 31,290,831 in Texas.

What industries lead in North Carolina and Texas?

Both states list pharmaceutical preparation manufacturing as the top industry. That shared label sits on $6.3B in North Carolina and $72.7B in Texas. Award counts are 429,746 in North Carolina and 530,634 in Texas. A shared peak is not a matched mix.

Are North Carolina and Texas closer on awards than on dollars?

Yes. Award counts are 429,746 in North Carolina and 530,634 in Texas. Stacked stocks are $6.3B versus $72.7B. These figures are USAspending.gov obligations, not outlays. Row count is not average award size.

Are North Carolina vs Texas figures Treasury outlays?

No. The $6.3B and $72.7B totals, and FY2026 amounts of $737.5M and $21.5B, are USAspending.gov obligations. Outlays are cash payments and can lag. Spending per capita ($66.77 vs $686.1) uses Census population where present. This packet does not publish outlays or average award size.